Pharmaceutical Business review

Sun Pharma generic Cymbalta gets tentative FDA approval

Sun Pharma said that these generic duloxetine hydrochloride delayed-release capsules, 20mg (base), 30mg (base), and 60mg (base) are indicated in the treatment of major depressive disorder (MDD), generalised anxiety disorder (GAD) and diabetic peripheral neuropathic pain (DPNP).

Duloxetine (Cymbalta, Ariclaim, Xeristar, Yentreve) is a serotonin-norepinephrine reuptake inhibitor manufactured and marketed by Eli Lilly.